Methotrexate treatment unruptured ectopic pregnancy report cases ongoing clinical trial patients unruptured ectopic pregnancy cm dimension outpatient protocol methotrexate citrovorum factor chemotherapy Methotrexate citrovorum days hCG titer consecutive days patients age years gravidity parity Twenty-three patients previous ectopic pregnancy patients methotrexate/citrovorum primary therapy persistent hCG titers conservative surgical procedure tubal pregnancies patient nos laparoscopy whereas patient nos nonlaparoscopic algorithm patients medical therapy surgery ectopic pregnancy cardiac activity intercourse cases specific identifiable risk factors ectopic pregnancies cardiac activity patients methotrexate-related side effects fourth dose none treatment side effects Hysterosalpingograms patients tubal patency involved side date pregnancies group intrauterine recurrent ectopic pregnancies methotrexate/citrovorum safe effective reproductive performance primary therapy unruptured ectopic pregnancy treatment persistent disease conservative surgical procedure 